NZ724912A - Transmucosal drug delivery devices for use in chronic pain relief - Google Patents
Transmucosal drug delivery devices for use in chronic pain reliefInfo
- Publication number
- NZ724912A NZ724912A NZ724912A NZ72491212A NZ724912A NZ 724912 A NZ724912 A NZ 724912A NZ 724912 A NZ724912 A NZ 724912A NZ 72491212 A NZ72491212 A NZ 72491212A NZ 724912 A NZ724912 A NZ 724912A
- Authority
- NZ
- New Zealand
- Prior art keywords
- drug delivery
- chronic pain
- transmucosal drug
- delivery devices
- pain relief
- Prior art date
Links
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161578755P | 2011-12-21 | 2011-12-21 | |
US61/578,755 | 2011-12-21 | ||
NZ62714512 | 2012-12-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ724912A true NZ724912A (en) | 2018-06-29 |
NZ724912B2 NZ724912B2 (en) | 2018-10-02 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009000745A (en) | Transmucosal delivery devices with enhanced uptake. | |
EA033256B1 (en) | Abuse-resistant two-layered devices for delivery of buprenorphine | |
CL2011000967A1 (en) | Dosage form comprising tapentadol in a slow release formulation, microcrystalline cellulose, polyvinyl alcohol, ethyl cellulose, colloidal silicon dioxide, sodium stearyl fumarate, optionally with pregabalin, and an opioid antagonist selected from naloxone, naltrexone or nalmefene, used as an analgesic . | |
EP2563450A4 (en) | Device for delivery of rheumatoid arthritis medication | |
MX2014000129A (en) | Drug combinations and uses in treating a coughing condition. | |
MX2012007933A (en) | Topical transdermal dexmedetomidine compositions and methods of use thereof. | |
MX2013007622A (en) | A combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease. | |
EA201400737A1 (en) | DELIVERY SYSTEM ON THE BASIS OF A PELLET SET WITH IMMEDIATE release of an ACTIVE SUBSTANCE | |
WO2014153385A3 (en) | Methods of treating metabolic disorders | |
MX2018010755A (en) | Montelukast transmucosal film. | |
MX2016006279A (en) | Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome. | |
WO2012082821A3 (en) | Melanoma treatments | |
WO2013083826A3 (en) | Glp-1 agonists | |
NZ724912A (en) | Transmucosal drug delivery devices for use in chronic pain relief | |
MX2020007860A (en) | Combination treatments for opioid crisis. | |
IL285091A (en) | Transmucosal drug delivery devices for use in chronic pain relief | |
TR201803744T4 (en) | Compositions containing naltrexone for use in the treatment of scleroderma. | |
MX357376B (en) | Pharmaceutical composition for use against inflammation and pain. | |
IN2014DN09359A (en) | ||
UA96455C2 (en) | Transmucosal delivery devices with enhanced uptake | |
IN2013MU02852A (en) | ||
UA55479U (en) | Method for preventing and treating miscarriage in patients with drug addiction and urogenital infections | |
UA33217U (en) | Method for treating chronic dermatosis | |
UA57850U (en) | Method for treating leiomyoma of uterus in patients of child-bearing age | |
UA52855U (en) | Method for complex nanotechnological detoxification in opioid addiction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 21 DEC 2019 BY DAVIES COLLISON CAVE PTY LTD Effective date: 20181005 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 DEC 2020 BY COMPUTER PACKAGES INC Effective date: 20191203 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 DEC 2021 BY COMPUTER PACKAGES INC Effective date: 20201201 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 DEC 2022 BY COMPUTER PACKAGES INC Effective date: 20211130 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 DEC 2023 BY COMPUTER PACKAGES INC Effective date: 20221130 |